NCT Number: NCT04363164
Phase: Phase 2
Trial Summary: Asymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized, open – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Acronym:
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives